As Canadian medstore continues to grow and advance our technologies and programs, we are committed to clear and consistent communication to our external audiences. Here we feature current and historic information concerning our technology, our pipeline and our corporate goals and achievements. Please check in often for the most recent press releases and news coverage.
Recent Press Releases
- 04.04.11 Cerulean Pharma Inc. Presents Phase 2a Clinical Data at American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
- 12.09.10 Cerulean Pharma Inc. Senior Executive to Present at the National Nanotechnology Innovation Summit
- 11.18.10 Cerulean Pharma Inc. Presents Clinical and Pre-Clinical Nanopharmaceutical Data at EORTC-NCI-AACR
- 11.15.10 Cerulean Pharma Inc. Closes $24 Million in Series C Financing
- 11.11.10 Cerulean Pharma Inc. to Present at BIO-Europe and EORTC-NCI-AACR
- 09.16.10 Cerulean Pharma Inc. CEO to Present at BioPharm AmericaTM 2010
- 08.25.10 Cerulean Pharma Inc. Presents Data on Nanopharmaceutical Development Candidates and Platform Technologies at American Chemical Society (ACS)
- 08.19.10 Cerulean Pharma Inc. to Convene Nanomedicine Pioneers at 2010 American Chemical Society (ACS)
- 03.10.10: Cerulean Pharma Inc. Appoints Two Senior Executives to Management Team
- 07.28.09 Cerulean Pharma Inc. Closes $10 Million Series B-1 Financing
- 06.23.09 Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc.
- 04.08.09 Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer